Answers are grounded in this paper and cite their sources.
When used as the initial treatment for chronic lymphocytic leukemia, fludarabine yields higher response rates and a longer duration of remission and progression-free survival than chlorambucil.
No takes yet. Share an insight, caveat, or question.
Kanti et al. (2000) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: